Quincy, MA (BlackNews.com) — There is a unique opportunity for Black prostate cancer patients to receive treatment with a drug approved by the FDA to increase survival and to participate in a groundbreaking project that will help define the future approach for treating prostate cancer.
During the past three years the Federal Drug Administration (FDA) has approved a number of new treatments for men with advanced prostate cancer which has created excitement among patients, doctors and researchers. Simultaneously, there have been breakthroughs in genomic research identifying different types of advanced prostate cancer. These two areas of development are foretelling brighter days ahead for prostate cancer patients.
The Stand Up to Cancer Foundation (SU2C) has funded a prostate cancer “Dream Team” project to bring new treatments and genomics research together to develop an approach for “Precision Therapy for Advanced Prostate Cancer” – a personalized approach to prostate cancer treatments.
The “Dream Team” includes some of the worldâ€™s leading prostate cancer doctors, scientists and researchers led by Dr. Arul Chinnaiyan (University of Michigan) and Dr. Charles Sawyers (Memorial Sloan Kettering Cancer Center). The Prostate Health Education Network (PHEN) is also a member of the Dream Team.
PHEN will outreach to the African American community to create awareness of this project, and educate prostate cancer patients and their families to ensure inclusion. With an understanding and appreciation of the prostate cancer crisis in Black America (Black men die from prostate cancer 2.4 times higher than all other men), SU2C established a goal for the Dream Team project to include at least 10% African American men.
African American men who meet the eligibility criteria for participating in the Dream Team project will be required to provide a tissue sample for genomic testing to determine their specific type of cancer. Prostate cancer survivors, patients and their family members can find complete details about this project and pre-register to participate on PHENâ€™s website at: www.prostatehealthed.org.
PHEN founder and president, Thomas A. Farrington, an African American prostate cancer survivor, stated, “As we move more and more towards personalized medicine where genetic biomarkers are going to be a critical element in determining the most effective treatments for individuals, African American men must participate in opportunities to define which treatments will be most effective for us.”
About PHEN (Prostate Health Education Network)
PHEN was founded in 2003 by Thomas A. Farrington, a prostate cancer survivor and author, with a mission to eliminate the African American prostate cancer disparity. PHENâ€™s ongoing initiatives include: Monthly support group meetings and webcasts, an “Annual Disparity Summit” on Capitol Hill, an “Annual Fatherâ€™s Day Rally Against Prostate Cancer” in partnership with churches nationwide, Monthly E-newsletters on prostate treatments and Clinical Trials, and a PHEN online Educational Television Series.
For additional information, contact:
Photo Caption: Terrence Howard, actor & SU2C member alongside Thomas A. Farrington, PHEN president and founder